Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs TRI✓SelectedUSD · TRIGSK vs TRI performance historyLatest closeAs of-2.32%11/17
Stock and ETF performance explorer

GSK vs TRI

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+286.7%
TRI return
+552.2%
Excess return
-265.5%
Maximum drawdown
-49.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioTRIExcessAlpha
1D-2.3%-3.8%+1.5%-1.2%
7D-3.0%-3.9%+0.9%-1.9%
30D+0.4%-4.4%+4.8%+1.3%
3M-1.2%+5.8%-7.0%-3.6%
6M+0.9%+27.7%-26.8%-8.3%
YTD+4.0%-18.0%+22.0%+6.3%
1Y+7.3%-20.8%+28.1%+11.0%
3Y+57.1%-19.1%+76.2%+58.7%
5Y+43.0%-4.9%+47.8%+34.7%
10Y+103.1%+204.5%-101.5%+24.5%
All+286.7%+552.2%-265.5%+62.1%

Cumulative growth

Daily Returns

Daily percentage return beside TRI.

Daily Out/Under-Performance

Portfolio return minus TRI return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × TRI return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded TRI wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling